Warning! GuruFocus detected
4 Medium warning signs
with EC8.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
FRA:EC8: Ordinary SharesDescription
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.94 | |||||
| Debt-to-EBITDA | 3.33 | |||||
| Interest Coverage | 5.37 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 2.19 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.2 | |||||
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 29.1 | |||||
| 3-Year FCF Growth Rate | 18 | |||||
| 3-Year Book Growth Rate | 5.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.34 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.48 | |||||
| 9-Day RSI | 45.31 | |||||
| 14-Day RSI | 43.3 | |||||
| 3-1 Month Momentum % | -13.97 | |||||
| 6-1 Month Momentum % | -11.36 | |||||
| 12-1 Month Momentum % | -20.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | |||||
| Quick Ratio | 1.05 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 210.14 | |||||
| Days Sales Outstanding | 66.57 | |||||
| Days Payable | 63.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.35 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| Forward Dividend Yield % | 1.33 | |||||
| 5-Year Yield-on-Cost % | 1.35 | |||||
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | 5.34 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.09 | |||||
| Operating Margin % | 15.33 | |||||
| Net Margin % | 10.13 | |||||
| FCF Margin % | 11.75 | |||||
| ROE % | 14.82 | |||||
| ROA % | 5.75 | |||||
| ROIC % | 7.49 | |||||
| 3-Year ROIIC % | 13.98 | |||||
| ROC (Joel Greenblatt) % | 46.16 | |||||
| ROCE % | 9.93 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.88 | |||||
| Forward PE Ratio | 13.21 | |||||
| PE Ratio without NRI | 14.15 | |||||
| Shiller PE Ratio | 43.57 | |||||
| Price-to-Owner-Earnings | 11.16 | |||||
| PEG Ratio | 2.08 | |||||
| PS Ratio | 1.4 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Free-Cash-Flow | 11.91 | |||||
| Price-to-Operating-Cash-Flow | 10.98 | |||||
| EV-to-EBIT | 13.48 | |||||
| EV-to-Forward-EBIT | 24.24 | |||||
| EV-to-EBITDA | 9.92 | |||||
| EV-to-Forward-EBITDA | 16.5 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-Forward-Revenue | 3.66 | |||||
| EV-to-FCF | 17.55 | |||||
| Price-to-GF-Value | 0.48 | |||||
| Price-to-Projected-FCF | 1.15 | |||||
| Price-to-DCF (Earnings Based) | 0.46 | |||||
| Price-to-DCF (FCF Based) | 0.93 | |||||
| Price-to-Median-PS-Value | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 7.42 | |||||
| FCF Yield % | 8.46 | |||||
| Forward Rate of Return (Yacktman) % | 9.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,211.534 | ||
| EPS (TTM) (€) | 3.918 | ||
| Beta | 0.68 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.86 | ||
| Volatility % | 34.67 | ||
| 14-Day RSI | 43.3 | ||
| 14-Day ATR (€) | 1.115403 | ||
| 20-Day SMA (€) | 55.35 | ||
| 12-1 Month Momentum % | -20.95 | ||
| 52-Week Range (€) | 53 - 74 | ||
| Shares Outstanding (Mil) | 30.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conmed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conmed Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conmed Corp Frequently Asked Questions
What is Conmed Corp(FRA:EC8)'s stock price today?
The current price of FRA:EC8 is €55.00. The 52 week high of FRA:EC8 is €74.00 and 52 week low is €53.00.
When is next earnings date of Conmed Corp(FRA:EC8)?
The next earnings date of Conmed Corp(FRA:EC8) is 2025-04-24 Est..
Does Conmed Corp(FRA:EC8) pay dividends? If so, how much?
The Dividend Yield %  of Conmed Corp(FRA:EC8) is 1.35% (As of Today), Highest Dividend Payout Ratio of Conmed Corp(FRA:EC8) was 2.5. The lowest was 0.19. And the median was 0.57. The  Forward Dividend Yield % of Conmed Corp(FRA:EC8) is 1.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers